Saying 1,000 words: 'Selfies' could to improve medication adherence

Cara Livernois | | Health Exec | Precision Medicine

Monitoring medication adherence may take a step forward with smartphone apps that require patients to snap 'selfies' before and after they take medication.

Appropriately titled “selfie medicine,” the app requires patients to take medications and then upload video proof to their clinic. This new avenue of remote patient monitoring aims to increase medication adherence.

Additionally, these types of monitoring apps are being researched with funding provided by the National Institute on Drug Abuse to see if patients with opioid addictions could use the app to avoid a relapse.

"If we can keep patients engaged, we can keep them in treatment longer," lead researcher Judith Tsui, of the University of Washington School of Medicine in Seattle, told the New York Times.

Read the full story below:

Selfie Medicine: Phone Apps Push People to Take Their Pills

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Trustees Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.

Cardiovascular Business
AMA to advocate for improved Medicare payments for office-based labs

SCAI and other healthcare groups want changes made to how healthcare providers are paid after performing office-based lab procedures. "As much as we love delivering care as doctors, if we are losing money doing something, we cannot sustain it," one cardiologist explained.